StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Acro Biomedical's enterprise value was $1.56M on Oct 19, 2026, against $42.00K a year earlier. Over the last 5 years it ranged from $37.71K to $286.85M, with a median of $6.30M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.56M+17.2%
2025Dec 31, 2025$1.33M+3114.8%
2024Dec 31, 2024$41.33K-99.3%
2023Dec 29, 2023$6.30M-97.7%
2022Dec 30, 2022$270.17M-3.2%
2021Dec 31, 2021$279.04M+101.5%
2020Dec 31, 2020$138.50M-20.3%
2019Dec 31, 2019$173.84M-5.5%
2018Dec 31, 2018$183.87M–

More Acro Biomedical figures

See a number that looks wrong?